40 results
8-K
EX-99.1
ADPT
Adaptive Biotechnologies Corp
14 Feb 24
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
4:15pm
% over the corresponding periods. This growth was more than offset by an expected reduction in GNE amortization in the IM business.
clonoSEQ test
DEFA14A
8vdem5c
23 Apr 21
Additional proxy soliciting materials
4:50pm
424B5
zldpxdtdmbkwt8fl7iti
16 Jul 20
Prospectus supplement for primary offering
4:26pm
424B5
wsllavq p45662
14 Jul 20
Prospectus supplement for primary offering
5:01pm